首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis and carbonic anhydrase isoenzymes I and II inhibitory effects of novel benzylamine derivatives
【24h】

Synthesis and carbonic anhydrase isoenzymes I and II inhibitory effects of novel benzylamine derivatives

机译:新苄胺衍生物的合成与碳酸酐酶同工酶I和II抑制作用

获取原文
获取原文并翻译 | 示例
           

摘要

Synthesis and carbonic anhydrase inhibitory properties of novel diarylmethylamines 22-25 and sulfonamide derivatives 26-28 were investigated. Acylation of methoxy-substituted benzenes with benzene carboxylic acids, reduction of ketones with NaBH4, conversion of alcohols to azides, Pd-C catalyzed hydrogenation of azides afforded title compounds 22-25. Compounds 22, 24 and 25 were converted to sulfonamide derivatives 26-28 with MeSO2Cl. The inhibitory effects of novel benzylamine derivatives 22-28 were tested on human carbonic anhydrase (hCA, EC 4.2.1.1) isozymes hCA I and II. The results demonstrated that compound 28 was found to be the best inhibitor against both hCA I (K-i: 3.68 mM) and hCA II (K-i: 9.23 mM).
机译:研究了新型二芳基甲胺的合成和碳酸酐酶抑制性能22-25和磺酰胺胺衍生物26-28。 用苯羧酸甲氧基取代的苯并酰化,用NaBH 4还原酮,将醇转化为叠氮,Pd-C催化萃取叠氮化物质化合物22-25。 将化合物22,24和25用MesO 2 Cl转化为磺酰胺衍生物26-28。 在人碳酸酐酶(HCA,EC 4.2.1.1)上检测新苄胺衍生物22-28的抑制作用。 结果证明,发现化合物28是抗HCA I(K-I:3.68mm)和HCA II(K-I:9.23mm)的最佳抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号